An interventional study of Visco-Circumferential-Suture-Trabeculotomy in Primary Open Angle Glaucoma. and Rigid probe Viscotrabeculotomy in Primary Open Angle Glaucoma. in Primary Open Angle Glaucoma, sponsored by Mansoura University. Status unknown. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-12-27.
Sponsored by Mansoura University · Not applicable, Interventional, and Treatment
Visco-Circumferential-Suture-Trabeculotomy versus Rigid probe Viscotrabeculotomy in Primary Open Angle Glaucoma.
Introduction Glaucoma is the leading cause of irreversible visual loss worldwide. Primary open angle glaucoma (POAG) is the most common type of glaucoma accounting for 74% of all glaucoma cases (1, 2). Trabeculectomy is still the most commonly performed glaucoma surgery worldwide (3). However, trabeculectomy has several vision-threatening complications as ocular hypotony, choroidal detachment and bleb related infections (4). Therefore, in the recent years, bleb independent less invasive procedures as canaloplasty (5,6), gonioscopy-assisted transluminal trabeculotomy (GATT) (7,8) and ab externo circumferential trabeculotomy (6,9) have become increasingly popular because of their great efficacy and excellent safety profile. Despite the successful outcomes and the few postoperative complications of GATT in juvenile and adult POAG, however on the downside, surgeons with less experience performing GATT procedure may initially struggle with it. Also, GATT requires a goniolens and a reasonably clear cornea to visualize the nasal angle. Introducing instruments into the anterior chamber also poses an increased risk for damage to intraocular structures (10, 11). Looking at ab externo trabeculotomy, for many years, many authors have demonstrated its efficacy in lowering IOP in congenital (12, 13, 14), juvenile (15, 16) and adult open angle glaucomas (6, 9, 17). Trabeculotomy ab externo techniques include conventional probe trabeculotomy, viscotrabeculotomy (VT) (17), 360 - degree suture trabeculotomy (9) , viscocircumferential -suture trabeculotomy (VCST) (14) and trabeculotomy with the use of illuminated microcatheter.(15,18). Although the illuminated microcatheter helps to cannulate SC safely, however its cost constitutes a financial burden in many countries. VCST was proved to be effective for reduction of IOP in PCG as it offers the advantages of performing 360 circumferential trabeculotomy with a great ease and a low cost (14). The aim of the present study was to compare the surgical outcomes of (VCST) and rigid probe VT in patients with POAG.
Purpose:
This study aims to compare the surgical outcomes of (VCST) and rigid probe VT in patients with POAG.
Methods:
The study is conducted at Mansoura university ophthalmic Center. Sample size has been calculated using Cochran's formula with a 95% confidence level and Z value of 1.95. This comparative study was conducted on 166 eyes of 107 patients with medically uncontrolled primary open-angle glaucoma diagnosed and operated upon in the Mansoura Ophthalmic Center of Mansoura University, Egypt between February 2017 and December 2020. The study follows the tenets of the Declaration of Helsinki. All patients of the study received a clear explanation of the study design, the surgical procedures and their possible consequences and they gave written informed consent.
Preoperative Evaluation All of the patients underwent a full ophthalmological examination, particularly estimation of the best corrected visual acuity (BCVA) (the decimal notation was converted to LogMAR), slit lamp examination, IOP measurement by Goldmann's applanation tonometry, gonioscopy using Goldmann 3-mirrors goniolens for angle grading using Schaffer's grading system and fundus examination. Visual field (VF) assessment was performed by SITA strategy perimetry (Humphrey, central 24-2 standard strategy). Retinal nerve fiber layer (RNFL) thickness and optic disc were evaluated using a spectral domain optical coherence tomography (OCT; Topcon, Japan). The number of antiglaucoma medications was recorded.
Eyes with primary open-angle glaucoma, with a gonioscopically open angle, an IOP above 21 mm Hg despite the maximally tolerated antiglaucoma medications, glaucomatous visual field defects, and glaucomatous optic disc appearance, in the absence of any obvious cause for glaucoma, were included in the study.
Patients with primary angle-closure glaucoma, secondary glaucomas, and who were on anticoagulant therapy and cannot stop treatment or with media opacity that interfere with visual field testing or OCT imaging were excluded from the study.
In patients suffering bilateral POAG (59 patients), randomization to either VCST or VT was applied to the first operated eye while the other eye was automatically assigned to the other procedure and included in the study. All surgical procedures were performed by the same experienced surgeon (A.S.E.).
Surgical Technique:
Surgical techniques of both Visco-Circumferential-Suture-Trabeculotomy (VCST) and rigid probe Viscotrabeculotomy (VT) were described previously in details.(14, 17) In Visco-Circumferential-Suture-Trabeculotomy (VCST), exposure of the operative field through a corneal traction suture (vicryl 6/0) placed superiorly was followed by a superior limbal-based conjunctival flap and a paracentesis. After adequate hemostasis, a superficial rectangular scleral flap 4×4 mm was fashioned and dissected forward toward the limbus. A deep sceral flap (2×2 mm) was then created toward the limbus underneath the superficial flap exposing the scleral spur and deroofing SC. Viscoelastic (Healon GV, Pfizer, NY) was gradually injected (using a standard 30 G viscocanalostomy cannula) into the ostia of SC (dilate SC and facilitate suture progression into the canal). Then, the 5/0 polypropylene suture tip was cauterized into a blunt tip (to ensure atraumatic probing of SC). The tip was inserted into the left ostium of SC using a microsurgical forceps and advanced through the whole circumference of the canal. When the tip presented to the right ostium the AC was filled with a viscoelastic through the paracentesis and traction was applied to approximate both ends of the 5/0 polypropylene suture, thus creating a visco-360-degree trabeculotomy.
For the viscotrabeculotomy group, the surgical procedure involved a fornixbased conjunctival incision followed by creation of a partial thickness (about 50% thickness) triangular (4×4×4 mm) scleral fap, followed by localization of Schlemm's canal by radial incisions straddling the limbus. High viscosity sodium hyaluronate (Healon GV, Pfzer) was then slowly injected into both ends of Schlemm's canal. Trabeculotomy was completed using the standard Harm's trabeculotome (Geuder Instruments), the scleral fap was then secured tightly with interrupted 10/0 Nylon sutures and conjunctival closure ensued. For the trabeculectomy group the fornix-based conjunctival incision was followed by mitomycin C application in a concentration of 0.3 mg/mL for 3 min through soaked surgical sponge inserted underneath the conjunctival fap and over the sclera posterior to the limbus then thoroughly irrigated by 200 mL of sterile normal saline. This was followed by dissection of the scleral fap which was rectangular (4×3 mm), followed by trabeculectomy, peripheral iridectomy and then secure closure by 10/0 nylon sutures. Filtration was judged arbitrarily according to the surgeon's experience and the conjunctiva was then closed securely .
For both groups postoperative treatment consisted of topical steroids (dexamethasone) and antibiotic (ofoxacin) five times daily with gradual taper over a 5 week period.
Cycloplegia (cyclopentolate) was used 3 times daily for the first postoperative week and then discontinued. Patients were examined on the first postoperative day and then postoperative follow up visits were scheduled at weeks 1 and 2 then months 1, 2 and 3 and then 3 monthly till the end of the 24th month (months 6, 9, 12, 15, 18, 21 and 24). Complications were noted and managed accordingly. The primary outcome measure was the IOP. Secondary outcome measures included the BCVA and number of IOP lowering medications. Success was defned as [15] an IOP ≤ 18 mmHg (criteria 1), an IOP ≤ 16 mmHg (criteria 2), IOP ≤ 14 mmHg (criteria 3) and ≤ 12 mmHg (criteria 4) and/or IOP reduction by ≥ 30% of baseline IOP (last IOP measurement immediately before surgery) without IOP lowering medications (complete success) (qualifed success was defned as IOP controlled according to the same criteria with/without IOP lowering medications), without the need for further surgery for IOP reduction and without any vision threatening complications or hypotony (IOP ≤ 5 mmHg).
Statistical analysis:
Data were analysed with IBM SPSS. Repeated measure ANOVA and paired t tests were used to compare the preoperative and postoperative variables in each group. Assessment of the data normality will be done using both histogram plot and Shapiro-Wilk's test. The comparison between the two groups was done by Independent samples T test for numerical variables and Chi-square test for categorical variables. Fisher's exact p values were chosen where there was an expected count of less than 5. Kaplan-Meier survival curves were plotted to estimate the mean survival time and probabilities of failure at diferent follow-up stages in the both groups.. For all tests, P value of less than 0.05 will be considered significant.
References
Filous A, Brunová B. Results of the modified trabeculotomy in the treatment of primary congenital glaucoma. J AAPOS. 2002 Jun;6(3):182-6. doi:
10.1067/mpa.2002.123431. PMID: 12075295.
Elwehidy AS, Bayoumi NHL, Abd Elfattah D, Hagras SM. Surgical Outcomesof Visco-Circumferential-Suture-Trabeculotomy Versus Rigid Probe
Trabeculotomy in Primary Congenital Glaucoma: A 3-Year RandomizedControlled Study. J Glaucoma. 2022 Jan 1;31(1):48-53. doi:
10.1097/IJG.0000000000001944. PMID: 34628421.
1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.
This study's planned enrollment of 166 is above the median of 65 across 1,272 interventional studies indexed under Glaucoma.
Browse Glaucoma studies →Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other types of glaucomas and co-morbidities
-
Visco-Circumferential-Suture-Trabeculotomy in Primary Open Angle Glaucoma.
Procedure: Visco-Circumferential-Suture-Trabeculotomy in Primary Open Angle Glaucoma.
Rigid probe Viscotrabeculotomy in Primary Open Angle Glaucoma.
Procedure: Rigid probe Viscotrabeculotomy in Primary Open Angle Glaucoma.
A superior limbal-based conjunctival flap and a paracentesis. A superficial rectangular scleral flap 4×4 mm was fashioned and dissected forward toward the limbus. A deep sceral flap (2×2 mm) was then created toward the limbus underneath the superficial flap exposing the scleral spur and deroofing SC. Viscoelastic (Healon GV, Pfizer, NY) was injected (using a standard 30 G viscocanalostomy cannula) into the ostia of SC Then, the 5/0 polypropylene suture tip was cauterized into a blunt tip (to ensure atraumatic probing of SC). The tip was inserted into the left ostium of SC using a microsurgical forceps and advanced through the whole circumference of the canal. When the tip presented to the right ostium the AC was filled with a viscoelastic through the paracentesis and traction was applied to approximate both ends of the 5/0 polypropylene suture, thus creating a visco-360-degree trabeculotomy.
A fornixbased conjunctival incision followed by creation of a partial thickness (about 50% thickness) triangular (4×4×4 mm) scleral fap, followed by localization of Schlemm's canal by radial incisions straddling the limbus. High viscosity sodium hyaluronate (Healon GV, Pfzer) was then slowly injected into both ends of Schlemm's canal. Trabeculotomy was completed using the standard Harm's trabeculotome (Geuder Instruments), the scleral fap was then secured tightly with interrupted 10/0 Nylon sutures and conjunctival closure ensued.
The primary outcome measure was the IOP
Success was defned as \[15\] an IOP ≤ 18 mmHg (criteria 1), an IOP ≤ 16 mmHg (criteria 2), IOP ≤ 14 mmHg (criteria 3) and ≤ 12 mmHg (criteria 4) and/or IOP reduction by ≥ 30% of baseline IOP (last IOP measurement immediately before surgery) without IOP lowering medications (complete success) (qualifed success was defned as IOP controlled according to the same criteria with/without IOP lowering medications), without the need for further surgery for IOP reduction and without any vision threatening complications or hypotony (IOP ≤ 5 mmHg).
Time frame: 2 years
BCVA
Time frame: 2 years
number of IOP lowering medications.
Time frame: 2 years
No study locations are listed for this record.
Plan to share: Yes — supplemental digital content
Supporting information: Study protocol, Sap, Icf, Csr, Analytic code
No publications or documents are linked to this record.
This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mansoura University